Company: RNAC
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001453687-25-000060
Chunk: 6

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 6
---
(a)Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock8-K001-377983.411/13/2023

72

4.9(b)Certificate of Amendment to the Certificate of Designation of Series A Non-Voting Convertible Preferred Stock, dated March 26, 2024.8-K001-377983.13/28/20244.10Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock8-K001-377983.17/2/20244.11Form of Registration Rights Agreement, dated as of July 2, 2024, by and among the Registrant and the Investors named therein.8-K001-3779810.27/2/20244.12Description of Securities———Filed herewith10.1#Amended and Restated 2016 Incentive Award Plan and form of award agreements thereunderS-1333-28120410.18/2/202410.2#2016 Employee Stock Purchase PlanS-1/A333-21155510.36/8/201610.3#Amended and Restated Cartesian Therapeutics, Inc. 2018 Employment Inducement Incentive Award Plan, and forms of award agreements thereunder———Filed herewith10.4#Cartesian Therapeutics, Inc. 2016 Stock Incentive Plan, and forms of award agreements thereunderS-8333-27648699.11/12/202410.5#Non-Employee Director Compensation Program———Filed herewith10.6#Form of Indemnification Agreement for Directors and OfficersS-1333-21155510.55/24/201610.7†Amended and Restated License Agreement, dated as of May 31, 2017, by and between the Registrant and Shenyang Sunshine Pharmaceutical Co., Ltd.10-Q001-3779810.68/11/201710.8†Manufacturing Services Agreement, dated as of August 1, 2014, by and between the Registrant and Shenyang Sunshine Pharmaceutical Co., Ltd.S-1333-21155510.105/24/201610.9(a)Lease Agreement by and between BRE-BMR Grove LLC and Selecta Biosciences, Inc. dated July 23, 201910-Q001-3779810.311/8/201910